Acquisition of Vilebrequin (Tables)

9 Months Ended

Oct. 31, 2013

Business Combinations [Abstract]

Schedule of the summary of components of purchase price allocation for acquisition of vilebrequin

Purchase price:
Cash paid	$	87,573
Notes issued		18,633
Fair value of contingent consideration		5,452
	$	111,658
Allocation:
Current assets	$	25,793
Property, plant and equipment		5,724
Identifiable intangible assets		68,847
Other non-current assets, net		15,274
Assumed liabilities		(12,938	)
Deferred income taxes		(17,820	)
Goodwill		26,778
	$	111,658